Investor Relations

Sunshine Heart is a global medical technology company, committed to the commercialization of C-Pulse®, an implantable, non-blood contacting, heart assist therapy for the treatment of people with class III and ambulatory class IV heart failure. Sunshine Heart is listed on the NASDAQ Capital Market.

Press Releases

Posted on May 3, 2016
EDEN PRAIRIE, Minn., May 03, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced today its financial results and provided a company update for the first quarter ended March 31, 2016.  The Company will host a conference call and webcast at 9:00 AM ET today to discuss its financial ...

Read More

Posted on Apr 27, 2016
EDEN PRAIRIE, Minn., April 27, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) today announced that its first quarter 2016 results will be released on Tuesday, May 3, 2016, before the open of the stock market. The company will host a conference call and webcast at 9:00 AM ET that mornin...

Read More

Posted on Mar 7, 2016
EDEN PRAIRIE, Minn., March 07, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (Nasdaq:SSH) announced today that its Chief Executive Officer and President, John Erb, is scheduled to present at the Cowen and Company 36th Annual Health Care Conference in Boston, MA on March 8th at 10:40 AM ET.  ...

Read More

Events & Presentations